X0508 4 2024-03-08 0000009326 BALCHEM CORP BCPC 0001908271 Tignor Michael Brent C/O BALCHEM CORPORATION 5 PARAGON DRIVE MONTVALE NJ 07645 true SVP & Chief HR Officer false Common Stock 2024-03-08 4 M 0 4200 85.4 A 13707 D Common Stock 2024-03-08 4 S 0 3261 157.0675 D 10446 D Common Stock 2024-03-08 4 S 0 2078 158.2233 D 8368 D Stock Options (right to buy) 85.4 2024-03-08 4 M 0 4200 0 D 2027-02-21 Common Stock 4200 4200 D Exercise of fully vested non-qualified stock options. Includes acquisition of shares (company match) under the Balchem Corporation 401(k) plan. This transaction was executed in multiple sales ranging from $157.0000 to $157.1900 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. This transaction was executed in multiple sales ranging from $158.0000 to $158.7850 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. Stock options that vested 20% on February 21, 2018, 40% on February 21, 2019, and 40% on February 21, 2020, and are exercisable. /s/ Hatsuki Miyata, Attorney-in-Fact for Michael Brent Tignor 2024-03-12